My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
Nov./Dec. 2009
Vol. 19 No. 11
Global ID
IDSA Joins Stop TB Partnership’s TB/HIV Working Group

The Stop TB Partnership has made IDSA an organizational member of its TB/HIV working group, a reflection of IDSA’s increasingly visible work on these twin global health threats.

Housed within the World Health Organization (WHO), the Stop TB Partnership was formed more than a decade ago as a network of international organizations, donors, and governmental and non-governmental groups—all committed to eliminating the deadly scourge of TB. The partnership has seven working groups to focus energy and attention on specific challenges in fighting TB, including drug-resistant TB, new TB drugs, and expansion of the Directly Observed Therapy Short-Course (DOTS) treatment strategy.

IDSA’s membership in the TB/HIV working group will provide a new way to advocate for improvements in policies and programs designed to combat these two epidemics, which have formed a deadly synergy that threatens to unravel gains in treating HIV. Christine Lubinski, IDSA vice president for global health, will serve as IDSA’s representative on the TB/HIV working group.

In ratifying a proposal to accept IDSA, the partnership noted IDSA’s recent work on co-infection through its Center for Global Health Policy. In particular, the partnership drew attention to the Global Center’s call for a presidential initiative on TB and for a comprehensive strategy to combat HIV/TB co-infection, as detailed in its issue brief, “Deadly Duo: The Synergy Between HIV/AIDS & Tuberculosis.” For more information about the Stop TB Partnership, visit this website.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
From the President: IDSA Priorities for the Year Ahead
IDSA Calls for Global Commitment to Create 10 New Antibiotics by 2020
Medicare in 2010: No More Payment for Consultation Codes; Possible Cuts Looming
IDSA Journal Club
Annual Meeting Coverage
Updates on H1N1 and Seasonal Influenza
Understanding Opposition and Barriers to Vaccination
Preventing HIV Infection, Managing Drug Interactions
Self Tests for HIV May Be Possible, Opt-Out Testing Has Lifesaving Potential
Powerful Film Chronicles Early Days of AIDS Pandemic
Gram-Negative Resistance Grows at Frightening Pace
Increased Resistance Complicates UTI and SSTI Treatment
Using Electronic Tools and Health Records in ID
New TB Drugs on the Horizon, But TB and HIV/AIDS Challenges Remain
A Special Thanks to all the supporters of the 47th Annual Meeting of IDSA
Patient Care and Science
EIN Update: Intestinal Complications, Oseltamivir, and H1N1
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medicare Disburses Incentive Payments for 2008 PQRI
Deadline for Identity Theft Policies Extended to June 1, 2010
New Medicare Resource Answers H1N1 Vaccine Billing Questions
Global ID
Global Center Releases Issue Brief on Broad Benefits of HIV/AIDS Response
IDSA Joins Stop TB Partnership’s TB/HIV Working Group
Policy and Advocacy
IDSA, Other Experts Urge White House to Modify H1N1 Guidance for Health Care Workers
Your Colleagues
Welcome, New IDSA Members!
Education & Resources
How to Claim CME/CPE Credit from the IDSA Annual Meeting
Use Your Member Discount at the ID/HIV Career Center
New Clinical Practice Guideline Pocketcards Now Available

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.